December 2nd 2020
|
Reading time: 1 Min
In collaboration with Israeli Ministry of Health, Teva Pharmaceuticals Industries Ltd, who is marketing Clonex 2mg Tablets, wish to draw the public's attention to a graphic misprint on the side panel of the product's package, on the below listed batches only.
The side panel mistakenly mentions, in small font, that each tablet contains 0.5mg. Whereas on its front panels the correct dosage of the product – 2mg, appears clearly, accurately and in large font.
It is emphasized that the product itself contains a dosage of 2mg – as it is printed on the front panels of the package and in large font, as well as on the product's blister. The product is safe for use. The barcode is also accurate so there is no practical risk of mistaken dispensing at the pharmacy.
Teva is currently making packaging adjustments to correct the misprint in the product's side panel.
|
Product |
SLE Catalogue code |
Barcode |
Batch number |
Expiration date |
|
Clonex 2mg |
2CK06010 |
7290000800585 |
109692 |
30/09/2023 |
|
Clonex 2mg |
2CK06010 |
7290000800585 |
109694 |
30/09/2023 |
|
Clonex 2mg |
2CK06010 |
7290000800585 |
109705 |
30/09/2023 |
We apologize for the inconvenience this may cause and thank you for your cooperation and understanding.
For any questions or inquiries, please email us at safety.israel@teva.co.il
Sincerely,
Teva Pharmaceutical Industries Ltd. Israel
